ArticleJournal of the American Academy of DermatologyPublished
Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of the American Academy of Dermatology
- Published
- Topic
- Clinical care
- Subject terms
- Adolescents; Plaque Psoriasis; Patient-reported Outcomes; Oral Peptide; Icotrokinra; Iconic-lead
- PubMed ID
- 42144198
- Added to directory
- Source checked